Full Text View
Tabular View
Study Results
Related Studies
Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
This study has been completed.
Study NCT00796744   Information provided by US Biotest, Inc.

First Received on November 20, 2008.   Last Updated on August 27, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Foot Ulcer, Diabetic
Diabetic Foot
Additional conditions recognized in this trial
Foot Ulcer
Ulcer
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Diabetic Angiopathies
Diabetic Neuropathies
Endocrine System Diseases
Foot Diseases
Leg Ulcer
Pathologic Processes
Skin Diseases
Skin Ulcer
Vascular Diseases
Interventions listed in this trial
NorLeu3-A(1-7) in a gel formulation
Additional drug interventions recognized in this trial
Angiotensin I (1-7)
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
US Biotest, Inc.
National Institutes of Health (NIH)
Derma Sciences, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services